Digestive Diamine Oxidase Enzyme For Supplements Market (By Ingredient; By Final Dosage Form) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global digestive diamine oxidase enzyme for supplements market was valued at USD 22.55 million in 2022 and it is predicted to surpass around USD 39.11 million by 2032 with a CAGR of 5.66% from 2023 to 2032.

Digestive Diamine Oxidase Enzyme For Supplements Market Size 2023 to 2032

Key Pointers

  • The ingredient segment is predicted to grow at a CAGR of 5.66% by revenue from 2023 to 2032. 
  • The demand for diamine oxidase in the final dosage form (FDF) is anticipated to grow at a CAGR of 5.37% by revenue during the forecast period. 
  • The European region is estimated to grow at the fastest CAGR of 7.1% from 2023 to 2032. 
  • North America led the market and accounted for a 32.2% share of the global revenue by ingredient in 2022.

Report Scope of the Digestive Diamine Oxidase Enzyme For Supplements Market

Report Coverage Details
Market Size in 2022 USD 22.55 million
Revenue Forecast by 2032 USD 39.11 million
Growth rate from 2023 to 2032 CAGR of 5.66%
Base Year 2022
Forecast Period 2023 to 2032
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Seeking Health, LLC; Eat All (Stada Group); Pure Encapsulations, LLC; Enzymedica, Inc.; Swanson; XYMOGEN; Klaire Labs.

 

Manufacturers are increasingly fortifying food and beverage products with enzymes, probiotics, and prebiotics. This is attributed to the consumer demand for food items with higher nutritional and fiber content. Digestive ingredients such as digestive diamine oxidase are widely used in supplements to avoid the risk of gastrointestinal diseases. This is expected to fuel the growth of the market over the forecast period.

The support of authoritative bodies such as the European Commission and the EPA toward the production and consumption of naturally-derived ingredients is likely to act in favor of the digestive diamine oxidase for the supplements industry. This scenario has pushed manufacturers to use naturally-derived ingredients.

In addition, supplement manufacturers are increasingly incorporating functional ingredients into products to increase their nutritional value. Ingredient suppliers and supplement manufacturers are focused on product innovation to expand their portfolio of probiotics and probiotic-based foods. This also aims to cater to the specific nutrition requirements of consumers with digestive health problems. The numerous new product launches are indicative of rising demand for digestive health food and beverages.

Increasing product awareness and robust branding by manufacturers are propelling the market growth. Rising incidences of chronic diseases and deficiencies are further augmenting the demand for functional foods. Digestive problems such as diarrhea, cramps, abdominal pain, bloating, and constipation occur due to a variety of reasons. In addition, certain conditions such as gastroesophageal reflux disease (GERD), diverticulitis, irritable bowel syndrome (IBS), and Crohn’s disease increase the risk of severe digestive issues. The demand for DAO enzymes has witnessed growth with a higher prevalence of digestive problems globally.

Ingredient Insights

The ingredient segment is predicted to grow at a CAGR of 5.66% by revenue from 2023 to 2032. The demand for DAO is being driven by the rising cases of food allergies coupled with the rising demand for functional foods. Consumer awareness of gut health and the prevention of gastrointestinal disorders has compelled manufacturers to use DAO as the primary ingredient in digestive supplements. In addition, the aging populace is also fueling the demand for DAO health supplements. As people age, their digestive system can become less efficient, leading to several health issues. DAO can help support gut health and promote overall health and prevent the risk of food allergies.

Furthermore, there is a growing demand for natural, specialty, and organic food items, particularly among high-income consumers. These consumers are willing to pay a premium price for products that are perceived as healthier or more environmentally friendly. As a result, food items containing digestive health ingredients like probiotics, prebiotics, and digestive enzymes have become increasingly popular among consumers looking for natural and organic alternatives to conventional products.

Final Dosage Form (FDF) Insights

The demand for diamine oxidase in the final dosage form (FDF) is anticipated to grow at a CAGR of 5.37% by revenue during the forecast period. Digestive Diamine Oxidase (DAO) supplements are typically packaged in the form of oral capsules or tablets. These dosage forms are designed to protect the DAO enzyme from degradation in the acidic environment of the stomach and deliver it in an intact manner to the small intestine.

Supportive regulatory initiatives and favorable initiatives from governments globally are also supporting the growth of the FDF segment. Growing technological innovations in the supplement sector also offer lucrative opportunities for the players operating in the digestive health products market. The Federation of European Nutrition Societies (FENS) and the European Society for Clinical Nutrition and Metabolism (ESPEN) fund and invest in various nutritional foods and nutraceutical businesses, thereby, fueling the growth of the segment.

There is a growing presence of branded and private-label products as well as retail channels in the digestive diamine oxidase for the supplements industry. This results in the addition of new and interesting flavors of digestive health products to make them more appealing to consumers. This remains the popular trend in the market. Companies are also using natural ingredients, which are often perceived as being healthier and more sustainable, to develop products that are in line with consumer demands.

Regional Insights

The European region is estimated to grow at the fastest CAGR of 7.1% from 2023 to 2032. The prevalence of histamine intolerance is higher in Europe due to differences in diet and genetic factors. For example, fermented foods and drinks, which are common in many European countries, are known to be high in histamine and can trigger symptoms in people with histamine intolerance.

The demand for digestive enzymes in Europe is primarily driven by increasing awareness of digestive health and the benefits of digestive enzyme supplements. Digestive enzyme supplements are designed to help break down and digest food more efficiently, which can help alleviate digestive symptoms like bloating, gas, and indigestion.Another factor driving the demand for digestive enzymes in Europe is the increasing popularity of plant-based diets. Plant-based diets can be higher in fiber, which can be difficult to digest and may require additional digestive enzymes to break them down and absorb nutrients from plant foods. This is a promising driver for future market growth.

North America led the market and accounted for a 32.2% share of the global revenue by ingredient in 2022. Changes in diet and lifestyle have significantly contributed to the growing demand for digestive health products in the region. Consumers in the region consume large portions of processed and fast foods, which can be harder to digest. This, combined with a sedentary lifestyle, can lead to numerous digestive issues.

In recent years, there has been an increase in awareness and concern about digestive health and several consumers are realizing that a healthy gut is essential for overall well-being. This has fueled the demand for DAO-based supplements in the region.

Digestive Diamine Oxidase Enzyme For Supplements Market Segmentations:

By Ingredient

By FDF

By Regional

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
  • Central & South America
    • Brazil
  • Middle East & Africa
    • South Africa

Frequently Asked Questions

The global digestive diamine oxidase enzyme for supplements market size was reached at USD 22.55 million in 2022 and it is projected to hit around USD 39.11 million by 2032.

The global digestive diamine oxidase enzyme for supplements market is growing at a compound annual growth rate (CAGR) of 5.66% from 2023 to 2032.

The North America region has accounted for the largest digestive diamine oxidase enzyme for supplements market share in 2022.

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers